Neonatal group B streptococcal disease in Finland: A ten-year nationwide study

Pediatric Infectious Disease Journal

Volumn 18, Issue 9, 1999, Pages 806-810

  Kalliola, Satu ^a   Vuopio Varkila, Jaana ^a   Takala, Aino K ^a   Eskola, Juhani ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Epidemiology; Group B Streptococcus; Neonatal sepsis; Serotyping

Indexed keywords

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; FINLAND; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN MORTALITY; PREMATURITY; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LABORATORIES, HOSPITAL; MALE; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SURVIVAL RATE;

EID: 0032858167     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199909000-00012     Document Type: Article

References (43)

1. Mercer BM, Briggs RG. Group B Streptococcus and pregnancy. Pediatr Ann 1996;25:206-14.
2. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: Saunders, 1995: 980-1054.
3. Aavitsland P, Hoiby EA, Lystad A. Systemic group B streptococcal disease in neonates and young infants in Norway 1985-94. Acta Paediatr 1996;85:104-5.
4. Centers for Disease Control. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45(R-7):1-24.
5. American Academy of Pediatrics, Committee on Infectious Diseases and Committee of Fetus and Newborn. Revised guidelines for prevention of early onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-96.
6. Wessels MR, Kasper DL. The changing spectrum of group B streptococcal disease. N Engl J Med 1993;328:1843-4.
7. Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis 1985;7:458-67.
8. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med 1988;319:1180-5.
9. Baker CJ, Rench MA, Kasper DL. Response to type III polysaccharide in women whose infants have had invasive GBS infection. N Engl J Med 1990;322:1857-60.
10. Edwards MS, Fusilier PA, Rench MA, Kasper DL, Baker CJ. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay. Infect Immun 1984;44:257-61.
11. Eisenstein TK, De Cueninck BE, Resavy D, Shockman GD, Carey RB, Swenson RM. Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay. J Infect Dis 1983;147:847-56.
12. Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994;62: 3236-43.
13. Wessels MR, Paoletti LC, Pinel J, Kasper DL. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Infect Dis 1995:879-84.
14. Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996;98:2308-14.
15. Baker CJ, Paoletti LP, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999;179:142-50.
16. Larsson C, Stålhammar-Carlemalm M, Lindahl G. Experimental vaccination against group B Streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha. Infect Immun 1996;64:3518-23.
17. Madoff LC, Paoletti LC, Tai JY, Kasper DL. Maternal immunization of mice with group B streptococcal type III polysaccharide beta C protein conjugate elicits protective antibody to multiple serotypes. J Clin Invest 1994;94:286-92.
18. Madoff LC, Michel JL, Gong EW, Rodewald AK, Kasper DL. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun 1992;60:4989-94.
19. Baker CJ, Barrett FF. Group B streptococcal infections in infants: the importance of the various serotypes. JAMA 1974;230:1158-60.
20. Wilkinson HW. Analysis of group B streptococcal types associated with disease in human infants and adults. J Clin Microbiol 1978;7:176-9.
21. Harrison LH, Dwyer DM, Johnson JA. Emergence of serotype V group B streptococcal infection among infants and adults [Letter]. J Infect Dis 1995;171:513.
22. Blumberg HM, Stephens DS, Modansky M, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996;173:365-73.
23. Lin FYC, Clemens JD, Azimi PH, et al. Capsular polysaccharide types of group B streptococcal isolates from neonates with early onset systemic infection. J Infect Dis 1998;177: 790-2.
24. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis 1998;177: 998-1002.
25. Takala AK, Eskola J, Peltola H, Mäkelä PH. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis 1989;8: 297-302.
26. Saarinen M, Takala AK, Koskenniemi E, et al. Spectrum of 2836 cases of invasive bacterial or fungal infections in children: results of prospective nationwide five-year surveillance in Finland. Clin Infect Dis 1995;21:1134-44.
27. Wilkinson HW, Facklam RR, Wortham EC. Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun 1973;8:228-35.
28. Vital Statistics 1994. Helsinki: Central Statistics Office of Finland.
29. Finnish Perinatal Statistics 1993. National Research and Development Centre for Welfare and Health.
30. Hervás JA, Gonzáles L, Gil J, Paoletti LC, Madoff LC, Benedi VJ. Neonatal group B streptococcal infection in Mallorca, Spain. Clin Infect Dis 1993;16:714-8.
31. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in Metropolitan Atlanta. J Infect Dis 1990;162: 672-7.
32. Zangwill KM, Schuhcat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 1992;41:25-32.
33. Kurki T, Hiilesmaa V. Raskausajan infektioseulonnan laajentamisen perusteita. (Basics of widening pregnancy related infection screening.) Suom Lääkäril 1997;26:2947-50.
34. Dillon HC Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987;110:31-6.
35. Faxelius G, Bremme K, Kvist-Cristensen K, et al. Neonatal septicemia due to group B Streptococcus: perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 1988;16:423-30.
36. Schuchat A, Wenger J. Epidemiology of group B streptococcal disease: risk factors, prevention strategies and vaccine development. Epidemiol Rev 1994;16:374-402.
37. Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease-United States, 1993-1995. MMWR 1997;46:473-6.
38. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994;13:623-9.
39. Insel RA. Maternal immunization to prevent neonatal infections. N Engl J Med 1988;319:1219-20.
40. Vesikari T, Janas M, Grönroos P, et al. Neonatal septicaemia. Arch Dis Child 1985;60:542-6.
41. Anthony BF, Concepcion NF. Group B Streptococcus in a general hospital. J Infect Dis 1975;132:561-7.
42. Kvam AI, Efstratiou AE, Bevanger L, et al. Distribution of serovariants of group B streptococci in isolates from England and Norway. J Med Microbiol 1995;42:246-50.
43. Chun CSY, Brady LJ, Boyle MDP, Dillon HC, Ayoub AM. Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis 1991;163:786-91.